Nexell Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 4.71%
- Profit Growth 211.12%
- Ebitda -367.06%
- Net Worth 36.17%
- Total Assets 83.74%
About Nexell Laboratories
Nexell Laboratories Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2008 and has a history of 16 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chitikena Vanitha and Nagiswara Vudatala serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232TG2008PTC058111
- Company No.
058111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Agriculture
Pharma
Who are the key members and board of directors at Nexell Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chitikena Vanitha  | Director | 11-Mar-2008 | Current |
| Nagiswara Vudatala | Director | 11-Mar-2008 | Current |
Financial Performance of Nexell Laboratories.
Nexell Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.71% increase. The company also saw a substantial improvement in profitability, with a 211.12% increase in profit. The company's net worth Soared by an impressive increase of 36.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexell Laboratories?
In 2023, Nexell Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Medical Hub Enterprises Private Limited
Chitikena Vanitha and Nagiswara Vudatala are mutual person
- Rrr Events & Media Private Limited
Nagiswara Vudatala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nexell Laboratories?
Nexell Laboratories has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexell Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexell Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.